Abcam Competitors and Similar CompaniesClear all
Abcam's competitors and similar companies include BioLegend, Bio-Techne, Humanigen and LGC.
 Abcam Abcam is a life sciences company that identifies and develops biological, protein, and custom cell engineering tools. |  Bio-Techne Bio-Techne is a company that provides researchers in life science and clinical diagnostics with reagent instruments, custom manufacturing, and testing services. |  Humanigen Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science. |  LGC LGC is a life science tools company providing components and solutions for high-growth application areas. | ||
Founding Date | Founding Date 1998 | Founding Date 2002 | Founding Date 1981 | Founding Date 2000 | Founding Date 1842 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Cambridge, GB HQ Hangzhou Shi, CN Shanghai, CN Hong Kong, HK Tokyo, JP Branford, US Burlingame, US see more | Locations San Diego, US HQ Beijing, CN Tokyo, JP | Locations Minneapolis, US HQ Toronto, CA Praha, CZ Copenhagen, DK Noyal Châtillon Sur Seiche, FR Noyal Châtillon Sur Seiche, FR Planegg, DE see more | Locations Burlingame, US HQ Dublin, IE London, GB Kansas City, US | Locations Teddington, GB HQ São José Dos Campos, BR Sofia, BG Milton, CA Pointe Claire, CA Beijing, CN Shanghai, CN see more |
Employees | Employees 1,49229% increase | Employees 6781% decrease | Employees 3,0502% increase | Employees 233% decrease | Employees 90111% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11.2 b | Valuation ($) 4.3 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) £361.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $1.2b (FY, 2024) | Revenue (est.) $2.5m (FY, 2022) | Revenue (est.) £152m (FY, 2024) |
Cost of goods | Cost of goods £37.3m (FY, 2022) | Cost of goods N/A | Cost of goods $389.3m (FY, 2024) | Cost of goods N/A | Cost of goods £92.8m (FY, 2024) |
Gross profit | Gross profit £324.4m (FY, 2022) | Gross profit N/A | Gross profit $769.7m (FY, 2024) | Gross profit N/A | Gross profit £59.1m (FY, 2024) |
Net income | Net income (£8.5m) (FY, 2022) | Net income N/A | Net income $168.1m (FY, 2024) | Net income ($70.7m) (FY, 2022) | Net income £7.9m (FY, 2024) |
Operating ⚠ | |||||
Patent Applications | Patent Applications N/A | Patent Applications N/A | Patent Applications 270 (FY, 2022) | Patent Applications 17 (FY, 2017) | Patent Applications N/A |
Products | Products 130 k (FY, 2020) | Products N/A | Products 350 (FY, 2021) | Products N/A | Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 78.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 131.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
BioLegend
HQ
San Diego, US
Employees
678↓ 1% decrease
BioLegend is a company that develops and manufactures antibodies and reagents.
View companyBio-Techne
HQ
Minneapolis, US
Employees
3,050↑ 2% increase
Bio-Techne is a company that provides researchers in life science and clinical diagnostics with reagent instruments, custom manufacturing, and testing services.
View companyHumanigen
HQ
Burlingame, US
Employees
2↓ 33% decrease
Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science.
View companyLGC
HQ
Teddington, GB
LGC is a life science tools company providing components and solutions for high-growth application areas.
View company